Curis to Present at BIO-Europe 2003
Thursday November 13, 8:51 am ET
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov. 13, 2003--Curis, Inc. (NASDAQ:CRIS - News) announced today that Daniel Passeri, Curis' President and Chief Executive Officer, will speak at the upcoming BIO-Europe 2003 International Partnering Conference being held at the Congress Center in Frankfurt, Germany on November 17-19, 2003. Mr. Passeri's presentation is scheduled for 4:30 PM on Tuesday, November 18. Mr. Passeri will present an update on Curis' business model and a review of its therapeutic product development programs.
The BIO-Europe International Partnering Conference is a forum where international decision makers in the biotechnology, pharmaceutical, and financial sectors can meet to initiate and develop partnerships among their companies.
About Curis, Inc.
Curis, Inc. is a therapeutic drug development company. The Company's technology focus is on regulatory pathways that control repair and regeneration. Curis' product development involves the use of proteins or small molecules to modulate these pathways. Curis has successfully used this technology and product development approach to produce several promising drug product candidates in the fields of kidney disease, neurological disorders, cancer, and alopecia (hair loss). For more information, please visit the Curis web site at www.curis.com.
Contact:
Curis, Inc.
Christopher U. Missling, Ph.D., 617-503-6587
or
Marc F. Charette, Ph.D., 617503-6629
Source: Curis, Inc. |
